More work needs to be done to examine the real world effects of the commonly prescribed diabetes drug empagliflozin, new research in the journal Diabetes Therapy finds.
Jun 14, 2017
0
0
A drug that lowers blood sugar levels for people with type 2 diabetes has also been revealed to significantly reduce the risk of both cardiovascular and kidney disease.
Jun 13, 2017
1
41
Painkillers considered harmless by the general public are associated with increased risk of cardiac arrest, according to research published today in the March issue of European Heart Journal - Cardiovascular Pharmacotherapy.
Mar 15, 2017
1
267
A 10-year trial involving osteoarthritis and rheumatoid arthritis patients in 13 countries reveals new insights on the cardiovascular safety of widely used nonsteroidal anti-inflammatory drugs and COX-2-specific inhibitors, ...
Nov 14, 2016
0
0
A new scientific statement from the American Heart Association provides guidance on how to manage the drug interactions of cholesterol-lowering medications called statins with other select heart disease medications.
Oct 17, 2016
0
3
The number of cardiovascular drugs in the research pipeline has declined across all phases of development in the last 20 years even as cardiovascular disease has become the number one cause of death world-wide, according ...
Aug 29, 2016
0
0
The world's most commonly used Type 2 diabetes drug, Metformin, may be 'repurposed' to treat non-diabetic conditions according to researchers from the University of Dundee.
Aug 22, 2016
0
5
Although the recently FDA approved cholesterol-lowering drugs, PCSK9 inhibitors, could substantially reduce heart attacks, strokes, and cardiovascular deaths, they would not be cost-effective for use in patients with heterozygous ...
Aug 16, 2016
0
1
(HealthDay)—The injectable drug Adlyxin (lixisenatide) has been approved to treat adults with type 2 diabetes, the U.S. Food and Drug Administration says.
Jul 28, 2016
0
5
Among nearly 120,000 adults with type 2 diabetes, there were no significant differences in the associations between any of 9 available classes of glucose-lowering drugs (alone or in combination) and the risk of cardiovascular ...
Jul 19, 2016
0
0
